Clinical Trial Update: Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)

View source ↗

Summary

Clinical trial update describing characterization of multiple myeloma participants with symptomatic relapse or refractory disease in Spain (CharisMMa study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Takeda

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma | Status: COMPLETED | Results posted: 2020-10-12